Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › ELL2, a new member of an ELL family of RNA polymerase II elongation factors

ELL2, a new member of an ELL family of RNA polymerase II elongation factors

US Patent 6008018 · Granted Dec 28, 1999

Estimated economic value: $19,307,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic targeting of the BAP1 complex in cancer2023
Small molecules for disrupting the super elongation complex and inhibiting trans2022
Therapeutic targeting of proteolytic cleavage of the mixed lineage leukemia gene2021
Therapeutic targeting of SET1B/compass pathway for treating cancers2021
Therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in c2020
Therapeutic targeting of SET1B/compass pathway for treating cancers2019
Therapeutic targeting of the interleukin 1 receptor-associated kinase 4 (IRAK4) 2018
Conformationally dynamic peptides2017
Methods of treatment using antibodies to follistatin-32009
Keratinocyte growth factor-2 polynucleotides2007
Method of treating reproductive system cancer by administering follistatin-32007
Follistatin-32005